8.Postow, M.A., Manuel, M., Wong, P., Yuan, J., Dong, Z., Liu, C., Perez, S., Tanneau, I., Noel, M., Courtier, A., et al. (2015). Peripheral T cell receptordiversity is associated with clinical outcomes following ipilimumab treat-ment in metastatic melanoma. J. Immunother. Cancer 3,2 3. 9.Hosoi, A., Takeda, K., Nagaoka, K., Iino, T., Matsushita, H., Ueha, S., Aoki, S., Matsushima, K., Kubo, M., Morikawa, T., et al. (2018). Increased diver- sity with reduced ‘‘diversity evenness’’ of tumor inﬁltrating T-cells for the successful cancer immunotherapy. Sci.